End-of-day quote
Shanghai S.E.
03:30:00 03/06/2024 am IST
|
5-day change
|
1st Jan Change
|
9.43
CNY
|
-3.18%
|
|
-4.07%
|
-31.57%
|
Fiscal Period: December |
2023
|
---|
Capitalization
1 |
5,773
|
Enterprise Value (EV)
1 |
6,234
|
P/E ratio
|
74.9
x
|
Yield
|
0.73%
|
Capitalization / Revenue
|
4.07
x
|
EV / Revenue
|
4.4
x
|
EV / EBITDA
|
33.3
x
|
EV / FCF
|
-22.2
x
|
FCF Yield
|
-4.51%
|
Price to Book
|
2.76
x
|
Nbr of stocks (in thousands)
|
4,18,968
|
Reference price
2 |
13.78
|
Announcement Date
|
26/04/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,734
|
1,792
|
1,417
|
EBITDA
1 |
379.1
|
384.1
|
187
|
EBIT
1 |
309.4
|
290.7
|
78.57
|
Operating Margin
|
17.84%
|
16.22%
|
5.54%
|
Earnings before Tax (EBT)
1 |
285.3
|
289.3
|
75.46
|
Net income
1 |
234.1
|
246.3
|
75.1
|
Net margin
|
13.5%
|
13.74%
|
5.3%
|
EPS
2 |
0.6209
|
0.6533
|
0.1839
|
Free Cash Flow
1 |
-413.4
|
-164
|
-281
|
FCF margin
|
-23.84%
|
-9.15%
|
-19.82%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
Dividend per Share
|
-
|
0.2000
|
0.1000
|
Announcement Date
|
19/04/23
|
19/04/23
|
26/04/24
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Net Debt
1 |
361
|
574
|
461
|
Net Cash position
1 |
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.9524
x
|
1.495
x
|
2.463
x
|
Free Cash Flow
1 |
-413
|
-164
|
-281
|
ROE (net income / shareholders' equity)
|
18.2%
|
16.4%
|
4.03%
|
ROA (Net income/ Total Assets)
|
10.1%
|
7.11%
|
1.63%
|
Assets
1 |
2,317
|
3,462
|
4,608
|
Book Value Per Share
2 |
3.670
|
4.320
|
4.990
|
Cash Flow per Share
2 |
0.3600
|
0.5400
|
0.5800
|
Capex
1 |
535
|
448
|
328
|
Capex / Sales
|
30.88%
|
24.98%
|
23.16%
|
Announcement Date
|
19/04/23
|
19/04/23
|
26/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -31.57% | 563M | | +17.43% | 66.31B | | -1.02% | 48.46B | | +20.95% | 43.27B | | +29.55% | 27.41B | | +7.49% | 19.26B | | -4.65% | 16.61B | | +9.34% | 16.58B | | -16.33% | 14.41B | | -28.97% | 14.02B |
Other Specialty Chemicals
|